Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Tolerability of ACH04 in Healthy Adults
NCT02949089Phase 1Completed
- Sponsor
- Aché Laboratórios Farmacêuticos
- Start
- Jan 2013
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ACH04 in diarrhea, sponsored by Aché Laboratórios Farmacêuticos. Primary endpoint: Safety of rising multiple doses of ACH04 at 39 days. Started Jan 2013; status: completed.
02
Drugs
ACH04
03
Conditions
diarrhea
Beyond the preview
Go deeper on NCT02949089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02949089.